SC
ARRY

Steven Cohen’s Array Biopharma Inc ARRY Stock Holding History

Steven Cohen’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,503,248
Closed -$61M – 1661
2019
Q1 		$61M Sell
2,503,248
-4,035,974
-62% -$84M 0.28% 86
2018
Q4 		$93.2M Buy
+6,539,222
New +$99.2M 0.46% 56
2018
Q2 		– Sell
-448,200
Closed -$7.32M – 1279
2018
Q1 		$7.32M Sell
448,200
-5,264,426
-92% -$84.3M 0.03% 495
2017
Q4 		$73.1M Sell
5,712,626
-3,296,373
-37% -$37.5M 0.32% 77
2017
Q3 		$111M Buy
9,008,999
+6,602,999
+274% +$61.3M 0.49% 40
2017
Q2 		$20.1M Buy
2,406,000
+1,128,100
+88% +$9.23M 0.11% 246
2017
Q1 		$11.4M Sell
1,277,900
-292,741
-19% -$3.11M 0.06% 371
2016
Q4 		$13.8M Buy
+1,570,641
New +$11.6M 0.1% 249
2016
Q1 		– Sell
-952,200
Closed -$4.02M – 914
2015
Q4 		$4.02M Buy
+952,200
New +$4.35M 0.03% 446
2015
Q1 		– Sell
-903,300
Closed -$4.27M – 853
2014
Q4 		$4.27M Sell
903,300
-522,000
-37% -$2.06M 0.03% 461
2014
Q3 		$5.09M Buy
+1,425,300
New +$5.62M 0.04% 401

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Steven Cohen's ARRY Position: Q2 2019 in Review

Steven Cohen sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 2,503,248 shares — an estimated $61M sold.

Steven Cohen first reported a position in ARRY in Q3 2014 and held it in 11 quarters. The position peaked at $111M in Q3 2017. 319 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Steven Cohen reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • Steven Cohen sold 2,503,248 Array Biopharma Inc shares in Q2 2019, an estimated $61M.
  • Steven Cohen first reported a position in Array Biopharma Inc in Q3 2014 and held it in 11 quarters.
  • Steven Cohen's Array Biopharma Inc position peaked at $111M in Q3 2017.
  • 319 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Point72 Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.